Crude Oil Down 2%; Home Depot Posts Upbeat Earnings
Portfolio Pulse from Lisa Levin
US stocks traded lower with the Dow, NASDAQ, and S&P 500 all falling. Home Depot (HD) reported better-than-expected Q2 results and authorized a new $15 billion share repurchase program. Delcath Systems (DCTH), Novo Integrated Sciences (NVOS), and Siyata Mobile (SYTA) saw stock increases due to positive news, while F45 Training Holdings (FXLV), Design Therapeutics (DSGN), and Galecto (GLTO) experienced stock drops due to negative developments.
August 15, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Delcath Systems shares shot up after the company announced FDA approval of HEPZATO KIT for the treatment of adult patients with unresectable hepatic-dominant metastatic uveal melanoma.
FDA approval of a new treatment is a significant positive development for the company, likely to drive the stock price up.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Home Depot reported better-than-expected Q2 results and authorized a new $15 billion share repurchase program.
Positive earnings report and share repurchase program announcement are likely to boost investor confidence and drive the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Novo Integrated Sciences shares got a boost after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project.
The announcement of a new joint venture is a positive development for the company, likely to drive the stock price up.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Siyata Mobile shares were up following upbeat quarterly sales.
Positive quarterly sales report is likely to boost investor confidence and drive the stock price up.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Design Therapeutics shares were down after the company reported initial results from its Phase 1 multiple-ascending dose study of DT-216 for the treatment of Friedrich ataxia, which included injection site reactions.
Negative initial results from a Phase 1 study is likely to decrease investor confidence and drive the stock price down.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
F45 Training Holdings shares dropped after the company announced it intends to voluntarily delist and deregister its securities.
The announcement of voluntary delisting and deregistration of securities is a negative development for the company, likely to drive the stock price down.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Galecto shares fell after the company announced topline results from its Phase 2b GALACTIC-1 trial of GB0139 for idiopathic pulmonary fibrosis, which did not meet its primary endpoint. The company plans to discontinue development of GB0139.
Negative topline results from a Phase 2b trial and discontinuation of a drug development are negative developments for the company, likely to drive the stock price down.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100